Skip to main content
Clinical Trials/NCT02059577
NCT02059577
Completed
Phase 2

Nutritional and Dietary Treatment Study for Children/Adults With Autism

Arizona State University1 site in 1 country120 target enrollmentNovember 2011
ConditionsAutism

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Autism
Sponsor
Arizona State University
Enrollment
120
Locations
1
Primary Endpoint
Reynolds Intellectual Assessment Scales
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

70 children and adults with autism spectrum disorders will be enrolled in a 1-year, single-blind treatment study. Assessments will be conducted at the beginning and end of the study, including measurements of nutritional, metabolic, and digestive status and assessments of autism severity and overall functioning. Half of the participants will be randomized into a treatment study, and half will be randomized to no changes in their current treatments. Treatments will be added in a sequential manner over 12 months, including vitamin/minerals, essential fatty acids, carnitine, digestive enzymes, and healthy, gluten-free, casein-free diets. A dedicated team of nutritionists, nurses, and physicians will support and monitor the participants throughout the study.

A group of 50 neurotypical children and adults, of similar age and gender, will be included for comparison.

Registry
clinicaltrials.gov
Start Date
November 2011
End Date
April 2013
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Inclusion Criteria - Autism Group
  • Diagnosis of autism spectrum disorder (autism, PDD-NOS, or Asperger's) by a psychiatrist, psychologist, or developmental pediatrician
  • Verification of diagnosis by an ADOS evaluation (conducted by ASU staff)
  • Age of 2.5 years to 60 years
  • Enrollment Criteria - Non-autism Group
  • No diagnosed mental disorders, including autism spectrum disorders, ADHD, depression, anxiety, etc.
  • No first-degree relatives of individuals with autism (no siblings or parents)
  • Age of 2.5 years to 60 years -

Exclusion Criteria

  • Exclusion Criteria - Autism Group
  • Major changes in behavioral or medical treatments in the previous two months, or intention to make such changes during the 12 months of the study.
  • Usage of nutritional supplements (vitamins, minerals essential fatty acids, carnitine) or special diets in the previous two months
  • Exclusion Criteria - Non-autism Group 1) Usage of nutritional supplements (vitamins, minerals essential fatty acids, carnitine) or special diets in the previous two months

Outcomes

Primary Outcomes

Reynolds Intellectual Assessment Scales

Time Frame: 12 months

Pre and post test of intellectual ability

Childhood Autism Rating Scale

Time Frame: 12 months

Pre and post assessment of autism symptoms/severity

Vineland Adaptive Behavior Scale

Time Frame: 12 months

Pre and post evaluation of adaptive behaviors

Study Sites (1)

Loading locations...

Similar Trials